NCT05010005 2026-04-09
A Study of Ruxolitinib and Duvelisib in People With Lymphoma
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
Memorial Sloan Kettering Cancer Center
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
University of Pennsylvania
Princess Maxima Center for Pediatric Oncology